Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370391 · ClinicalTrials.gov registry record · NA
Comprehensive Behavioral Intervention for Tics
A NA study of Tic Disorders, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05370391: Recruiting NA study of Tic Disorders, sponsored by University of Miami.
NCT05370391 is a NA study of Tic Disorders that is actively recruiting participants, run by University of Miami. The registered enrollment target is 200 participants, roughly in line with the 195-participant average among 9 other Tic Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05370391, a NA study of Tic Disorders, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to examine treatment outcomes of youth receiving the Comprehensive Behavioral Intervention for Tics (CBIT) and better understand the predictors, moderators, mediators and/or mechanisms of change for this intervention.
Primary Outcome
A single-item clinician-reported measure used to assess the severity of the youth's illness at the time of assessment. The CGI-S is rated on a 7-point scale ranging from 1 (slight psychiatric illness) to 7 (extremely severe psychiatric illness). Higher scores indicate greater symptom severity.
Conditions Studied
Interventions
- BEHAVIORAL Comprehensive Behavioral Intervention for Tics (CBIT)
Study Locations (1)
Florida
- University of Miami - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-09-09 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT05370391 shows while recruiting
NCT05370391 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 195-participant average among 9 other Tic Disorders trials with a reported enrollment target.
The record links to 1 condition, with Tic Disorders appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Behavioral Intervention for Tics (CBIT) is the first listed.
NCT05370391 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05370391 about?
NCT05370391 is a clinical study titled "Comprehensive Behavioral Intervention for Tics". The purpose of this protocol is to examine treatment outcomes of youth receiving the Comprehensive Behavioral Intervention for Tics (CBIT) and better understand the predictors, moderators, mediators and/or mechanisms of change for this intervention.
What is the current status of trial NCT05370391?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-09-09. Estimated completion is 2027-01-31.
What conditions does trial NCT05370391 study?
This clinical trial studies the following conditions: Tic Disorders.
What interventions are being tested in trial NCT05370391?
The interventions under investigation include: Comprehensive Behavioral Intervention for Tics (CBIT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05370391?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05370391 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tic Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05370391's enrollment target sits among peer trials
200 3rd of 9 higher than 7 of 9 other Tic Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tic Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Remote Delivery of a Mindfulness-based Intervention for Tics
RECRUITING · NA
-
Trajectories of Change in Tourette Syndrome
RECRUITING · NA
-
Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder
RECRUITING · NA
-
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
RECRUITING · NA
-
Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics
COMPLETED · NA
-
Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI